glp-1 drug news today Risks of Ozempic, other drugs are at center of sweeping lawsuit that kicked off in Philadelphia Diabetes: New GLP-1 pill improves
Description
DeFronzo RA, Ratner RE, Han J, et al
What is Ozempic and what are some potential issues with it
A small trial including 8 patients with T1D showed improved postprandial hyperglycemia despite 20% insulin dose reduction (69)
Glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy adherence for patients with type 2 diabetes in a Medicare population
Research shows that virtual eating disorder treatment is as effective as in-person treatment, but each person and their care team should thoughtfully decide whats best for them personally
Navigating Access Issues Ask the Expert Kelly Wood, MD As an endocrinologist, what is your experience with newer weight loss drugs like semaglutide
